Table of Content


Introduction
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Overview
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Therapeutics Development
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Therapeutics Assessment
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Companies Involved in Therapeutics Development
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Drug Profiles
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Dormant Projects
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Discontinued Products
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Biogen Inc, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Bristol-Myers Squibb Co, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by ChemoCentryx Inc, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Chugai Pharmaceutical Co Ltd, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by GlaxoSmithKline Plc, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Humanigen Inc, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by iBio Inc, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Iltoo Pharma, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by InflaRx NV, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Kyowa Kirin Co Ltd, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Mabion SA, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Nanolek LLC, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Dormant Projects, 2021
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Discontinued Products, 2021